arrow
S

Sarah Alexandrou

faculty of medicine unsw sydney
H指数:10
被引数:684

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Tracking CDK1 Dynamics With a Novel Biosensor Mouse and Clinical Cohorts to Predict CDK4/6 Inhibitor Sensitivity in ER+ Breast Cancer

利用新型生物传感器小鼠和临床队列追踪CDK1动态,以预测ER+乳腺癌对CDK4/6抑制剂的敏感性

2026-10-110
OA
MDM2 inhibition restores p53 function to overcome dual endocrine and CDK4/6 inhibitor resistance in ER+ breast cancer

MDM2抑制通过恢复p53功能克服ER+乳腺癌对内分泌和CDK4/6抑制剂的联合耐药

2026-08-280
OA
Endocrine therapy reprogramming of breast cancer facilitates metastatic escape via upregulation of P-Rex1/Rac1 signalling

内分泌疗法对乳腺癌的重编程通过上调P-Rex1/Rac1信号通路促进转移性逃逸

2026-05-110
OAAI
BRRIAR lncRNA alters breast cancer risk by modulating interferon signaling in cis and in trans

BRRIAR lncRNA通过调节顺式和反式干扰素信号改变乳腺癌风险

2026-01-070
OAAI
The potential of epigenetic therapy to target the 3D epigenome in endocrine-resistant breast cancer
2024-01-055
OAAI
The androgen receptor is a tumor suppressor in estrogen receptor-positive breast cancer
2021-01-18151
OA
MDM2 inhibition in combination with endocrine therapy and CDK4/6 inhibition for the treatment of ER-positive breast cancer

MDM2抑制联合内分泌治疗和CDK4/6抑制治疗ER阳性乳腺癌

2020-08-1245
OAAI